drugset / Trial / NCT03145831
A Long-Term Safety Study of Somavaratan in Japanese Children With Growth Hormone Deficiency
NaSingle-groupOpen-labelTreatment
Summary
This study is a multi-center, open-label safety study assessing long-term somavaratan administration.
Timeline
- Start
- 2017-03-31
- Primary completion
- 2017-11-30
- Completion
- 2017-11-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Somavaratan | Protein / enzyme biologic | 3.5 mg/kg | Subcutaneous |